159 related articles for article (PubMed ID: 33773548)
1. The Potential of hsa-mir-106b-5p as Liquid Biomarker in Prostate Cancer Patients in Indonesia.
Bonnu CH; Ramadhani AN; Saputro RB; Sesotyosari SL; Danarto R; Astuti I; Haryana SM
Asian Pac J Cancer Prev; 2021 Mar; 22(3):837-842. PubMed ID: 33773548
[TBL] [Abstract][Full Text] [Related]
2. miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia.
Gunawan RR; Astuti I; Danarto HR
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1095-1099. PubMed ID: 36974566
[TBL] [Abstract][Full Text] [Related]
3. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
4. MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis.
Farré PL; Duca RB; Massillo C; Dalton GN; Graña KD; Gardner K; Lacunza E; De Siervi A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681793
[TBL] [Abstract][Full Text] [Related]
5. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J
Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034
[TBL] [Abstract][Full Text] [Related]
6. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
Song Y; Song C; Yang S
Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0107593 Suppresses the Progression of Cervical Cancer
Liao W; He J; Disoma C; Hu Y; Li J; Chen G; Sheng Y; Cai X; Li C; Cheng K; Yang C; Qin Y; Han D; Wen W; Ding C; Li M
Front Oncol; 2020; 10():590627. PubMed ID: 33585208
[TBL] [Abstract][Full Text] [Related]
10. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
11. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.
Pang C; Liu M; Fang W; Guo J; Zhang Z; Wu P; Zhang Y; Wang J
Cell Physiol Biochem; 2016; 39(3):1111-7. PubMed ID: 27562849
[TBL] [Abstract][Full Text] [Related]
12. Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.
Sancer O; Koşar PA; Tefebaşı MY; Ergün O; Demir M; Koşar A
Turk J Med Sci; 2022 Jun; 52(3):788-795. PubMed ID: 36326314
[TBL] [Abstract][Full Text] [Related]
13. Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer.
Khan MM; Serajuddin M; Bharadwaj M
Biomarkers; 2023 Mar; 28(2):227-237. PubMed ID: 36644827
[No Abstract] [Full Text] [Related]
14. Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Prostate-Specific Antigen Combined with Plasma miRNA-149 Expression in Patients with Prostate Cancer Based on Experimental Data and Bioinformatics.
Wang H; Yang L; Mi Y; Wang Y; Ma C; Zhao J; Liu P; Gao Y; Li P
Contrast Media Mol Imaging; 2022; 2022():6094409. PubMed ID: 35935308
[TBL] [Abstract][Full Text] [Related]
16. hsa-miR-106b-5p participates in the development of chronic thromboembolic pulmonary hypertension via targeting matrix metalloproteinase 2.
Miao R; Dong X; Gong J; Wang Y; Guo X; Li Y; Liu M; Wan J; Li J; Yang S; Wang W; Kuang T; Zhong J; Zhai Z; Yang Y
Pulm Circ; 2020; 10(3):2045894020928300. PubMed ID: 32699607
[TBL] [Abstract][Full Text] [Related]
17. Stability Assessment of Candidate Reference Genes in Urine Sediment of Prostate Cancer Patients for miRNA Applications.
Egidi MG; Cochetti G; Guelfi G; Zampini D; Diverio S; Poli G; Mearini E
Dis Markers; 2015; 2015():973597. PubMed ID: 26078486
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
Guo Z; He C; Yang F; Qin L; Lu X; Wu J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
[TBL] [Abstract][Full Text] [Related]
19. hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis.
Wang P; Zhang L; Yin S; Xu Y; Tai S; Zhang LI; Liang C
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):815-822. PubMed ID: 33978716
[TBL] [Abstract][Full Text] [Related]
20. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study.
Pełka K; Klicka K; Grzywa TM; Gondek A; Marczewska JM; Garbicz F; Szczepaniak K; Paskal W; Włodarski PK
Histochem Cell Biol; 2021 Mar; 155(3):423-433. PubMed ID: 33331954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
